Med BioGene Inc.

(MBI:PUR)

By |

Profile

Med Biogene Inc is a Canada based life science company. It is primarily focused on the development and commercialization of genomic-based clinical laboratory diagnostic tests. The company is engaged in managing the license and rights to GeneFx Lung, which is a proprietary gene expression-based test for identifying those patients with for early-stage non-small-cell lung cancer.

Contact Information

Website: www.medbiogene.com
Main Phone: +1 604 732-7332
Address: 598 East Kent Avenue South
State: BC
City / Town: Vancouver
Country: CAN
Postal Code: V5X 4V6

Issuer Information

Exchange: CDX
CEO: Iain Weir-Jones
Employees: 7
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)(541714)
$ 0.03 $ -0.02 (-40.00%)
Last Price 0.03 Change $ -0.02 Change % -40.00 Tick N/A
Bid N/A Bid Size 0.00 Ask 0.035 Ask Size 6,000.00
Open 0.03 High 0.03 Low 0.03 Prev Close 0.05
Last Trade Volume 6,000 52 Wk Hi 0.05 52 Wk Low 0.03
Market Cap 262,735 Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 8,757,835.00 EPS (TTM) -0.01 PE Ratio N/A Exchange TSXV